Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid commercial adoption and distribution of its patented DehydraTECH(TM) absorption technology, which is designed to improve oral uptake. Statistics show that some 7 million people die every year from cigarette smoking, and alternatives for nicotine delivery are desperately needed. Lexaria’s DehydraTECH-nicotine is already patent granted for oral nicotine delivery in Australia and pending in numerous other countries. The company noted that its DehydraTECH-powered purified nicotine white pouch formulation contains no tobacco, and studies show that its DehydraTECH-nicotine can be 10 to 20 times fast and deliver up to tenfold higher levels of nicotine into blood plasma from oral absorption than concentration-matched controls. LEXX’s NIC-H22-1 study is a human pharmacokinetic randomized, double-blinded, cross-over study with a minimum of 36 human volunteers who currently smoke cigarettes. The study objectives include determining the quantity of nicotine in blood at various time points and collecting vital-sign data, such as blood pressure, heart rate and respiratory rate; Lexaria will provide further updates and any relevant material findings as they become available.

To view the full press release, visit https://cnw.fm/OnTm3

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 28 patents granted and many patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com. 

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The Third Annual NECANN Illinois Cannabis Convention – The Only B2B Convention in Illinois

NECANN, a pioneer in developing engaging conventions for the cannabis industry, is proud to announce its third edition of The Illinois Cannabis Convention being held on June 2-3rd, 2023. This year’s event will build on the success of the 2022 Illinois Cannabis Convention, with scaled-up operations that will see even more exhibitors, presenters, products, and even attendees in what promises to be the best B2B cannabis convention in Illinois.

The event will be held at the Schaumburg Convention Center in Chicago from 10 AM to 3 PM. It will play host to cannabis enthusiasts, farmers, entrepreneurs, and investors, with discussion topics ranging from careers in cannabis to marijuana investment opportunities and challenges. Some of the presenters at this two-day event will include Rebecca Abraham, the Founder and President of Acute on Chronic; Nadav Aschner, a partner at The Roadman Law Group; Bennett Cawthon, the President of Streamline Farms; and Jennifer Clark, a Strategy and Operations Consultant at LaunchSpot Consulting.

NECANN has been developing conventions for the cannabis industry since 2014, offering an avenue for expanding market opportunities for entrepreneurs, investors, businesses, patients, educators, cannabis advocates, and consumers. Throughout the years, the company has refined its approach to conventions, adapting to the current state and potential of each local market it has ventured into thus far. In addition, its collaborative approach with the local industries and communities has helped set its conventions apart, stamping its place as the go-to cannabis convention in the United States.

The third annual Illinois Cannabis Convention draws from the learnings from NECANN’s previous events, promising an avenue where exhibitors can achieve consistently high returns, attendees can learn a lot, and the local cannabis market can grow. This is an event that understands the booming cannabis space, especially in Chicago. As such, it looks to tap into that growth and the buzz around cannabis to draw interested parties together in one place to exchange value, ideas, products, and knowledge on how to push the industry forward.

To learn more, please visit https://cnw.fm/EVW4N

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The 2023 Alternative Products Expo – Everything Counterculture Under One Roof

ZJ Events is proud to announce the 2023 Alternative Products Expo, the ultimate gathering for smoke shop owners, independent retailers, buyers, and counterculture enthusiasts. This event looks to build on the success and momentum of previous events dating back to 2019, which have achieved massive success and offered incredible value and exposure to attendees.

The Alternative Products Expo offers an avenue for anyone in the counterculture industry to connect with top manufacturers, explore the latest trends and innovations, and take advantage of exclusive show discounts in a fun and exciting atmosphere. Termed the largest vape, hemp, and counterculture expo, this event offers a unique and exciting experience with opportunities for everyone at the event. Such opportunities will range from bulk buying, experiencing the business’ fun side, enjoying specials and free samples, and having a sneak peek into new industry releases.

This upcoming event, held in Medellín, Colombia, will feature partners such as The Hemp Doctor, Cannavist, Mellow Fellow, Cannabis & Tech Today, and 3Chi. In addition, featured products will include disposables, nootropics, dietary supplements, Delta8, Vapes, CBD, and mushrooms, among others, making it the go-to event for a wide variety of niche industry players looking to find mainstream distribution and traditional marketing opportunities for their products.

ZJ Events has, since its inception, sought to address the public demand for better business gatherings that are different from the traditionally dull and ordinary conventions. This has birthed various shows including, but not limited to, the flagship Alternative Products Expo, Expo Verse, Biz Cann Expo, Inno Venture, Vape South America, and the USA CBD Expo. In addition to Medellín Colombia, the Alternative Products Expo will also take place in Dallas on July 13-15, 2023, and in Vegas on September 14-16, 2023, all with the same underlying theme of having everything counterculture under one roof.

To learn more, please visit https://cnw.fm/nopVp and https://cnw.fm/WsNmI

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Four New Patents Added to the Company’s Growing Patent Portfolio

  • Lexaria has received notifications of four new patents either awarded or allowed
  • After the awarding of these patents, Lexaria’s total patent portfolio will have grown to 32 granted patents worldwide
  • The new granted patent in Japan is under Patent Family #3: Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Agents
  • The new granted Australian patent is under Patent Family #18: Compositions and Methods for Enhanced Delivery of Antiviral Agents
  • The new allowed Canadian patent is under Patent Family #8: Compositions Infused with Nicotine Compounds and Methods of Use Thereof
  • The new allowed US patent is under Patent Family #21: Compositions and Methods for Treating Hypertension and is the first patent in the Patent Family

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms and the global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs through its patented DehydraTECH(TM) technology – has announced that the company has received notification of four newly awarded or allowed patents (https://cnw.fm/EDyAd). The new patents will add to Lexaria’s growing portfolio, bringing the total number of patents granted worldwide to 32, with several more pending.

Lexaria’s newly awarded or allowed patents include the following:

  • Japan: Lexaria’s new patent in Japan is under Patent Family #3: Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Agents. This patent is the fifth awarded in Japan, strengthening the company’s growing Japanese patent portfolio. Under this particular patent family, Lexaria has existing patents in Australia, India, Japan, and Mexico.
  • Australia: Lexaria’s new Australian patent is categorized under Patent Family #18: Compositions and Methods for Enhanced Delivery of Antiviral Agents. The new patent brings Lexaria’s total in Australia to ten and is the second patent in this Patent Family, following a similar patent in the United States awarded in 2022.
  • Canada: Lexaria’s Canadian patent under Patent Family #8: Compositions Infused with Nicotine Compounds and Methods of Use Thereof has been allowed. This will be Lexaria’s second patent in this Patent Family and follows a similar issuance in Australia in 2022.
  • United States: Lexaria has been notified that a new patent under Patent Family #21: Compositions and Methods for Treating Hypertension has been allowed in the US. The company believes this patent could provide significant importance in its pursuit of utilizing DehydraTECH-CBD concerning its expected upcoming FDA Investigational New Drug application. The outcomes of a series of hypertension studies already completed were instrumental in achieving this particular patent and is the first patent in the Patent Family.

When a patent is “allowed,” it means that the patent office has notified the company that it has been determined that they will soon grant the patent, often subject to some administrative tasks and/or fees.

Lexaria’s DehydraTECH technology speeds up delivery, increases bioavailability, increases brain absorption, improves drug potency, reduces drug administration cost, and masks unwanted taste. The company has conducted animal studies that demonstrated a propensity for DehydraTECH to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,700 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Two markets of penetration for Lexaria include cardiovascular drugs and CBD. The global cardiovascular drug market is expected to reach $173.48 billion by 2026 (https://cnw.fm/HTuz0). The global CBD market is expected to reach $111.8 billion by 2030 (https://cnw.fm/CJlRS). Lexaria’s DehydraTECH technology anticipates leveraging both markets and others, including oral nicotine, PDE5 inhibitors, and more avenues in which Lexaria has filed for patent protection for.

The new patents will allow Lexaria to continue its research and use of DehydraTECH for several indications. The patents offer protection on the company’s technology and allow it to explore further additional opportunities for use – reducing drug administration costs, enhancing efficacy, and more.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Emerges as a Major Issue in Thailand Upcoming Elections

The Bhumjaithai Party, a Thai political movement credited with helping to partially legalize cannabis, has accused opponents of using the issue for political gain ahead of the country’s May 14 election, claiming that cannabis reform is a must if it is to join any governing coalition.

Thailand changed its marijuana laws in June 2022, allowing licensed companies to grow and sell the substance solely for medical purposes. However, parliament failed to adopt a comprehensive marijuana act before it was disbanded in March to make room for election campaigning.

Recreational smoking has flourished in the legal void, prompting worry among critics who argue the legislation is too broad and too fast. The main prodemocracy parties, Move Forward and Pheu Thai, both of which are anticipated to win the majority of seats, claim that the liberalization of marijuana has been chaotic, encouraged marijuana usage and has fallen short of helping impoverished farmers as promised due to the high costs of investment.

The issue has also divided a generally conservative populace in a nation with tight drug laws, and many are concerned by the easy access to high-strength marijuana, especially among young people.

In response to the criticism, Supachai Jaisamutr, the Bhumjaithai party’s top marijuana official, cautioned that politics is masking the contribution of cannabis to Thailand’s economy, which is expected to reach at least $1.2 billion by 2025.

Thais are expected to vote in leaders for the 500 seats in the lower house on May 14, 2023. A 250-member Senate that was appointed by Prime Minister Prayuth Chan-ocha and his backers, however, plays a controversial role in the election. The Senate is expected to back the conservative party that wins the elections. Furthermore, it holds one-third of the total 750 votes for the prime minister after the government is formed.

The main conflict is considered one between conservative parties, particularly Prayuth’s United Thai Nation, which wants to retake power, and prodemocracy parties, which have been out of power since Prayuth’s coup in 2014. However, the marijuana controversy is playing a surprisingly significant role. Experts predict between 80 and 100 seats could be won by Bhumjaithai, the second-largest party, which is led by Health Minister Anutin Charnvirakul. The party would potentially have the final say in whether a government-forming coalition would be made up of prodemocracy forces or the conservative group.

Long-time supporters of marijuana decriminalization have been appalled by the politics of marijuana. They worry that the political commotion surrounding cannabis may result in restrictive regulations when the next administration debates the specifics of the Marijuana Act.

For small Thai cannabis businesses, the political conflict has overshadowed the biggest issue facing the domestic market: the illicit importation of marijuana from the United States or Laos, which is five times cheaper than Thai produce.

Marijuana is a divisive topic in many parts of the world, not just in Thailand, and enterprises such as IGC Pharma Inc. (NYSE American: IGC) that have opted to come up with pharmaceutical-grade medicines from this plant somehow avoid the controversy surrounding the plant since their work involves adhering to the strict drug-development laws in the jurisdictions where they intend to get their medicines approved for use in the healthcare system.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Federal Agencies Ease Rules on Previous Drug Use to Meet Labor Needs

As more states in the United States legalize the use of marijuana for recreational and/or medicinal use, the number of employers relaxing drug testing rules continues to increase. The federal government, which is the biggest employer in the country, has now followed suit, relaxing drug screening rules as agencies struggle to meet their labor needs in the tight job market.

Polls show that over one-half of Americans have used cannabis medicinally or recreationally, with majority reporting that they believe the drug should be legalized. Currently, the recreational use of cannabis is legal in 22 states as well as Washington, D.C., while the drug’s medicinal use is legal in the District of Columbia and 38 other states.

Officials have acknowledged that agencies such as the FBI and CIA have taken on more lenient regulations regarding past use of cannabis among job applicants. For example, the CIA announced in April of last year that applicants would need to avoid using cannabis for only 90 days before submitting an application, a huge change from the previous one-year eligibility requirement. The FBI also decreased its cannabis abstention requirement for individuals seeking employment from three years to one year.

In the last five years, the United States military has also given more than 3,000 new recruits a grace period of 90 days to take another test after they failed their entry drug tests. The Navy also launched a pilot program in 2021 that permits recruits to take another drug test 90 days after they failed entry drug tests.

Later in the year, the Biden administration will have the chance to impose limits on how far the government can dredge into the drug histories of individuals who apply for security clearance. Currently, individuals applying for a security clearance must reveal a detailed account of their use of illicit drugs during the last seven years. Background checks conducted before clearance can be investigated if an applicant has been truthful about their use of drugs.

The measure, which was introduced by Representative Jamie Raskin would make the use of cannabis irrelevant in reviews for security clearance, which are needed by most federal jobs. Under the proposed measure, the federal government would limit that time frame to five years for drugs other than cannabis, with applicants being required to disclose cannabis use only during the ninety days before they applied for the job.

Overall, federal employees are barred from using drugs such as cannabis once they receive clearance, even in legal-states, because the drug is still illegal under federal law.

As the drug-screening requirements ease, more people may consider using marijuana for therapeutic or recreational purposes. This increase in the number of users could boost marijuana demand, and that increased demand is likely to have a trickle-down effect on many industries in the economy, such as increasing the demand for indoor cultivation equipment from businesses such as Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BizCann Expo Shares Agenda Details for Upcoming Colombian Cannabis Expo

BizCann Expo, hosted by ZJ Events, is gearing up for its next event to be held May 21–22, 2023, in Medellín, Colombia. A premier cannabis event in South and Latin America, BizCann is designed to provide key information on innovation, entrepreneurship, and education on all aspects of the cannabis sector. This year’s two-day agenda features an impressive array of presentations from more than 20 speakers, including 3C Consulting founder and CEO Nic Easley,  GNC-Brands founder Juan Gonzalez, Global Cannabis Network Collective business developer Rosa Maria Puentes Velosa and Green Leaf Colombia cofounder and production manager Camilo Martínez. The event is built around four core pillars: unmatched educational opportunities, especially through engaging with thought leaders and industry experts; a deep dive into the legislative landscape and licensing requirements; essential entrepreneurship encouragement and insight; and invaluable collaboration with Latin and South American businesses. In addition, event organizers note that a key to the success of the expo is the carefully designed conference environment designed to optimize networking opportunities with top-level executives from a variety of streams including cultivators, legal advisors, accountants, entrepreneurs, license holders, service providers and seasoned investors. This year’s event location — Medellín, Colombia — offers the perfect cannabis expo destination. The city boasts a culture of cannabis consumption and a rich tapestry of cultural experiences, as well as accessibility to the U.S. market and excellent road infrastructure. “Medellín is poised to be a center for cannabis investment in the region, with more than $300 million expected to be invested nationally by the end of the year, helping to jumpstart canna-business opportunities in the region and encourage a thriving ecosystem,” the press release stated. “The event is colocated with the Alternative Products Expo and provides a gateway to suppliers, marketers and international investors into the demand-heavy and fast-developing markets of South America and Latin America.”

To view the full press release, visit https://cnw.fm/j8ZFm

About BizCann Expo

BizCann Expo, a production of ZJ Events, is a business and networking event for everything related to cannabis. Event founders were once exhibitors who, after attending countless tradeshow events, saw an opportunity to build upon their experience and create an event that combined the best they had seen with their own notion of what was missing in these business gatherings, thereby separating themselves from ordinary conventions. Since its beginning, the expo has focused on gathering the industry’s best under the same roof. For more information about the company, please visit www.BizCannExpo.com

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Schumer Applauds Refiling of Cannabis Banking Bill

Chuck Schumer, the Senate Majority Leader, has reaffirmed his commitment to pursuing marijuana banking legislation that includes criminal justice provisions and described the broader endeavor to undo the damage caused by the drug war as a moral duty for Congress. Schumer reiterated his intent to pass the SAFE Banking Act, which had been refiled the day before by bipartisan members of the house and senate, during his speech on the House floor this week. He also promised to keep working on a more comprehensive package that supports industry equity and justice for those impacted by the drug war.

The measure, which has undergone minor revisions since the previous session, would shield banks from federal regulators’ sanctions when they cooperate with cannabis businesses that are legal in their state. This most recent revision further clarifies that the safe harbor is extended to CDFIs and MDIs that provide commercial loans to minority-owned enterprises; this is a new clause that proponents pushed for during the previous Congress. The new bill also enables cannabis workers to access mortgage loans backed by the federal government.

While Schumer acknowledged the need for a banking fix, he also stated that work will continue on the SAFE Plus package, which is anticipated to include provisions for gun rights and expungements for marijuana users.

Earlier this month, Sherrod Brown, the chairman of the Senate Banking Committee, announced that his panel will handle cannabis banking reform on its own and leave equity and criminal justice recommendations to other committees with appropriate jurisdiction.

To enact any kind of marijuana reform this session, lawmakers will likely need to concentrate on smaller-scale marijuana laws such as the banking bill rather than more comprehensive justice-centered legalization due to the divided Congress and GOP-controlled house.

However, a recent senate vote has prompted some to wonder whether any minimal cannabis reform is feasible given the current makeup of Congress. A procedural attempt to advance a bipartisan measure that would have simply called for investigations into the medical benefits of marijuana for veterans with PTSD and chronic pain was rejected by senate Republicans.

In recent years, the House has enacted the standalone SAFE Banking Act in various forms, generally with bipartisan support. However, it has come to a standstill in the senate despite having both Republican and Democratic leadership.

Advocates had assumed that the bill would begin in the Senate this time, but it seems that legislators chose to press for bicameral action instead.

Many of the challenges that marijuana companies face, such as lack of access to banking services, don’t impact enterprises such as IGC Pharma Inc. (NYSE American: IGC) which follow federal rules guiding the way medicines are developed for human or animal use, even if those treatments include marijuana compounds including THC. As a result, the preclinical and clinical drug-development processes undertaken by such pharmaceutical companies often result in FDA approval once those drugs are found to be safe and efficacious.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Minnesota Senate Passes Measure to Legalize Cannabis

The senate in the state of Minnesota recently passed a measure to legalize cannabis. The measure, introduced by Senator Lindsey Port, was approved in a close vote of 34 to 33. This comes a few days after a companion reform resolution was approved in the House.

On the floor, Port stated that the prohibition of marijuana was a failed system that hadn’t achieved its desired objectives, noting that it had greatly cost communities of color. Port continued that the measure’s approval would help establish a system of regulation that worked for businesses and consumers in the state, while also ensuring that communities that were most impacted by prohibition had an opportunity to take part in the new market.  The senator added that the primary objectives were to legalize and regulate marijuana while also expunging prior cannabis convictions.

The senate-approved and house-approved measures have both been amended a couple of times throughout the approval process, with legislators working to revise policies around various issues and include public feedback. Many are confident that legalization will be enacted this year.

Under the SF 73 and HF 100 measures, individuals aged 21 years and older will be allowed to buy and possess up to two ounces of marijuana. They will also be permitted to grow no more than eight plants at home, four of which may be mature. The gifting of no more than two ounces of cannabis without remuneration will also be allowed between adults.

Counties and municipalities will also be in charge of establishing a system of licensed marijuana businesses, in addition to operating and owning government dispensaries. Furthermore, previous cannabis records will be expunged automatically if the reform is enacted, with the bills stipulating that the Bureau of Criminal Apprehension will be in charge of identifying individuals who are eligible and process their expungements.

With regard to levies, part of the tax revenue generated will be awarded as grants to support farmers with some of it also funding substance misuse treatment programs.

Earlier in January, Governor Tim Walz announced his biennial budget request, which included projections on the millions in marijuana tax revenues that his office estimates Minnesota will rake in once the reform is enacted. The request also included proposed funding to implement cannabis legalization and expungements.

The bill being advanced is a repetition of the 2021 House-passed legislation introduced by former Majority Leader Ryan Winkler. Winkler currently serves as campaign chairman of the MN is Ready advocacy coalition.

When marijuana prohibition comes to an end in Minnesota, plenty of opportunities will be opened to innovative state residents and nonresidents alike. For example, companies such as Advanced Container Technologies Inc. (OTC: ACTX), which supplies indoor cultivation equipment, will have more clients to serve.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

NECANN Connecticut Cannabis & Hemp Convention to Deep Dive Into the Rapidly Changing Cannabis Industry

The 2023 Connecticut Cannabis & Hemp Convention is being held at one of the most prestigious locations in Connecticut, the XL Center, 1 Civic Center Plaza in Hartford, CT on May 20-21, 2023. NECANN takes note of reputable brands, as well as creative entrepreneurs on the scene, to create a vibrant blend of exhibitors, speakers, and panelists, that keep attendees engaged and inspire repeat visits to events.

The convention attracts industry-leading professionals who will present the latest insights into the cannabis industry. With expert speakers and exhibitors, the convention will have it all: science, cultivation, new opportunities, legal, branding, business strategies, growth, policy reform, and more. The conference strives to address the latest topics in the cannabis industry while allowing attendees to learn from the luminaries who are driving growth.

The conference is arranged to offer meaningful networking opportunities and impactful insights that serve a broader purpose of managing the industry as it grows. It serves as a platform that promises to both inspire and engage the next generation of cannabis heavy hitters in cultivation, extraction, retail, branding, media, compliance, distribution, and everywhere in between.

Network, Learn, And Explore The Cannabis World!

The 2023 Connecticut Cannabis & Hemp Convention is designed to empowering attendees with all the products, news, technologies, and legal info available. It will offer ample networking opportunities to create potent connections with peers in the cannabis industry. Attendees will have the opportunity to relax after the enthusiasm of the show, celebrate success, and start a conversation over drinks.

Perfect for entrepreneurs, executives, and even consumers, the conference will feature a range of expert panelists and speakers that represent a wide range of professionals from across the cannabis industry. The seminar will attract hundreds of leading exhibitors, including pioneering leaders in the cannabis marketplace. The seminars are designed to display the latest industry advances, new technologies and products, legal and financial issues, along with real-world insights from the trenches.

The convention is an ideal platform for networking and discovering what’s new in the cannabis marketplace. In addition to providing insightful educational resources, it will offer exhibitors the opportunity to improve brand awareness. The event will also include question-and-answer sessions and panel discussions about legislation, political issues, and cannabis business opportunities.

To learn more, please visit https://cnw.fm/7vEi9.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.